ما هو علاج الخط الأول للعجز الجنسي ذي المنشأ العضوي؟

References

DOI: 10.1016/j.juro.2018.05.004

Men with ED should be informed regarding the treatment option of an FDA-approved oral phosphodiesterase type 5 inhibitor (PDE5i), including discussion of benefits and risks/burdens, unless contraindicated.

For men who are prescribed PDE5i, the dose should be titrated to provide optimal efficacy.

The FDA-approved oral phosphodiesterase type 5 inhibitors (PDE5i) available for management of ED in the U.S. include sildenafil, tadalafil, vardenafil, and avanafil.